Brussels, City of Innovators
With the support of Innoviris, their skills, their innovative ideas and their enthusiasm boost evolution in the Brussels-Capital Region. Meet the innovators that shape the future of Brussels.
![](https://www.innoviris.brussels/sites/all/themes/innoviris/img/bg-stories.jpg)
![](https://www.innoviris.brussels/sites/default/files/guilain.png)
Guilain
Sevriere
Guilain
Sevriere
fondateur de Bel Albatros
Story of Guilain
Guilain
Bel Albatros takes plastic waste and recycles it, transforming it locally into a responsible, sustainable new material that combines aesthetics with the qualities and characteristics of plastic. The...
![](https://www.innoviris.brussels/sites/all/themes/innoviris/img/bg-stories.jpg)
![](https://www.innoviris.brussels/sites/default/files/etienne-toffin.jpg)
Etienne
Etienne Toffin
Etienne
Etienne Toffin
Story of Etienne
Etienne
We're all researchers when it comes down to social innovation “This project is primarily about social innovation”, explains Etienne. “ValueBugs is a participative citizen research project where...
![](https://www.innoviris.brussels/sites/all/themes/innoviris/img/bg-stories.jpg)
![](https://www.innoviris.brussels/sites/default/files/robin_keunen.jpg)
Robin
Keunen
Robin
Keunen
Software Engineer chez Coop IT Easy
Story of Robin
Robin
Coop IT Easy is a cooperative committed to building digital commons and free software for social economy stakeholders.
![](https://www.innoviris.brussels/sites/all/themes/innoviris/img/bg-stories.jpg)
![](https://www.innoviris.brussels/sites/default/files/cd_2019_10_05_14_18_13-2.jpg)
Ludivine Verboogen & Romain Alderweireldt
Ludivine Verboogen & Romain Alderweireldt
Story of
“There is a paradox in rare disease research. Financing it is still problematic yet, at the same time, research into rare diseases has enabled us to make significant advances in more common diseases...
![](https://www.innoviris.brussels/sites/all/themes/innoviris/img/bg-stories.jpg)
![](https://www.innoviris.brussels/sites/default/files/mima_013.jpg)
Matthias
D’Huyvetter
Matthias
D’Huyvetter
Story of Matthias
Matthias
Matthias D’Huyvetter and Precirix are developing a radioactive medicine for cancer Precirix is developing CAM-H2 with radioactively marked antibodies to track down and treat cancer cells and...